Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Transgenomic Cmn (OTHER OTC: TBIO)

$0.21 USD -$0.05 (-19.23%)
Last Price $0.21
Net Change $-0.05 (-19.23%)
Bid $0
Ask Price $0
Open Price $0.26
Previous Close Price $0.26
High Price $0.26
Low Price $0.1711
Number of Trades 136
Volume 514,900
Fifty Two Week High $1.59 (2017-01-13)
Fifty Two Week Low $0.15 (2016-11-08)
Average Daily Volume 1,952,877
Share Outstanding 26,860 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $0
Recent Earnings $
Annual EPS $-0.25
Last Quarter EPS $
Market Capitalization $0.01B
Insider Shareholders % 0.019%
Annual Revenue $0B
No. Shares Outstanding 26,860
Inst. Shareholder % 0.03%
Annual Net Income $-0.01B
TTM Net Profit Margin $-307.54
1-Year Return -65%
3-Year Return -94.72%
5-Year Return -97.84%
5-Year Revenue Growth -95.12%
5-Year Earnings Growth -100%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD %
Dividends per Share $
Stock Split Ratio 1-30
Beta 0.05
Transgenomic provides innovative research tools to the genomics segment of the life sciences industry. These tools enable researchers to discover and understand variations in the human genetic code. The company believes its WAVE System, which incorporates its proprietary DNASep separation column and associated software, chemical reagents and other consumable items, will become a leading tool to analyze genetic mutations. The WAVE System allows researchers to analyze both known and unknown genetic mutations faster, with more accuracy and at a lower cost than other techniques.

TBIO News & Stock Updates